Literature DB >> 8290579

Tat-mediated delivery of heterologous proteins into cells.

S Fawell1, J Seery, Y Daikh, C Moore, L L Chen, B Pepinsky, J Barsoum.   

Abstract

The Tat protein of human immunodeficiency virus 1 (HIV-1) can enter cells efficiently when added exogenously in tissue culture. To assess if Tat can carry other molecules into cells, we chemically cross-linked Tat peptides (residues 1-72 or 37-72) to beta-galactosidase, horseradish peroxidase, RNase A, and domain III of Pseudomonas exotoxin A (PE) and monitored uptake colorimetrically or by cytotoxicity. The Tat chimeras were effective on all cell types tested, with staining showing uptake into all cells in each experiment. In mice, treatment with Tat-beta-galactosidase chimeras resulted in delivery to several tissues, with high levels in heart, liver, and spleen, low-to-moderate levels in lung and skeletal muscle, and little or no activity in kidney and brain. The primary target within these tissues was the cells surrounding the blood vessels, suggesting endothelial cells, Kupffer cells, and/or splenic macrophages. Tat-mediated uptake may allow the therapeutic delivery of macromolecules previously thought to be impermeable to living cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290579      PMCID: PMC43009          DOI: 10.1073/pnas.91.2.664

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  36 in total

1.  Effect of monensin on ricin and fluid phase transport in polarized MDCK cells.

Authors:  E L Melby; K Prydz; S Olsnes; K Sandvig
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

2.  Intracellular delivery of drugs by liposomes containing P0 glycoprotein from peripheral nerve myelin into human M21 melanoma cells.

Authors:  M Foldvari; C Mezei; M Mezei
Journal:  J Pharm Sci       Date:  1991-11       Impact factor: 3.534

3.  Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein.

Authors:  B S Weeks; K Desai; P M Loewenstein; M E Klotman; P E Klotman; M Green; H K Kleinman
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

4.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits.

Authors:  J M Wilson; M Grossman; C H Wu; N R Chowdhury; G Y Wu; J R Chowdhury
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

6.  Translocation mediated by domain II of Pseudomonas exotoxin A: transport of barnase into the cytosol.

Authors:  T I Prior; D J FitzGerald; I Pastan
Journal:  Biochemistry       Date:  1992-04-14       Impact factor: 3.321

Review 7.  Redirecting Pseudomonas exotoxin.

Authors:  D FitzGerald; I Pastan
Journal:  Semin Cell Biol       Date:  1991-02

8.  A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin.

Authors:  B E Vogel; S J Lee; A Hildebrand; W Craig; M D Pierschbacher; F Wong-Staal; E Ruoslahti
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

9.  A method for incorporating macromolecules into adherent cells.

Authors:  P L McNeil; R F Murphy; F Lanni; D L Taylor
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes.

Authors:  J Connor; L Huang
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  287 in total

1.  Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.

Authors:  Z Lai; I Han; G Zirzow; R O Brady; J Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

Authors:  V P Torchilin; R Rammohan; V Weissig; T S Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Tat-neutralizing antibodies in vaccinated macaques.

Authors:  Ilia Tikhonov; Tracy J Ruckwardt; Glen S Hatfield; C David Pauza
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery.

Authors:  Nathan P Gabrielson; Hua Lu; Lichen Yin; Dong Li; Fei Wang; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-07       Impact factor: 15.336

Review 5.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

6.  Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.

Authors:  Tien-Yi Lee; Yoon Shin Park; George A Garcia; Roger K Sunahara; James H Woods; Victor C Yang
Journal:  Mol Pharm       Date:  2012-03-28       Impact factor: 4.939

7.  Creation of a zymogen.

Authors:  Parit Plainkum; Stephen M Fuchs; Suthep Wiyakrutta; Ronald T Raines
Journal:  Nat Struct Biol       Date:  2003-02

Review 8.  Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.

Authors:  Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Journal:  AAPS PharmSci       Date:  2002

9.  Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists.

Authors:  Y N Chen; S K Sharma; T M Ramsey; L Jiang; M S Martin; K Baker; P D Adams; K W Bair; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

10.  New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.

Authors:  J P M Langedijk; T Olijhoek; D Schut; R Autar; R H Meloen
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.